Regulatory updates, compliance insights, and industry analysis from the ACPL team.
CDSCO has tightened post-market surveillance for medical devices in 2026 — new MDSW guidance, 48-hour recall rules, and risk-based audits.…
Read MoreCDSCO's new Prior Intimation pathway and interim import procedures are reshaping BA/BE study timelines in India. Here's what sponsors and…
Read MoreCDSCO's October 2025 draft guidance on Medical Device Software is reshaping how SaMD and AI/ML tools are classified and licensed…
Read MoreIndia's cosmetic import rules are tightening in 2026. This practical guide covers COS-1 to COS-2 approval, fees, timelines, and post-approval…
Read MoreCDSCO threatens rejection of 2+ year pending applications by Feb 14, 2026. New IVD import guidance and cosmetic enforcement actions…
Read More